Latest Sensipar Stories
Officials with the US Food and Drug Administration have halted a trial of the thyroid drug Sensipar following the death of a 14-year-old patient during clinical trials, various media outlets reported Tuesday.
EXTON, Pa., April 29 /PRNewswire/ -- BioTrends Research Group, Inc. recently published two syndicated reports focused on the management of bone and mineral metabolism in the US.
EXTON, Pa., April 30 /PRNewswire/ -- BioTrends Research Group, Inc. released ChartTrends(R): Bone and Mineral Metabolism in Dialysis, a syndicated publication offering comprehensive insight into the management of calcium, phosphorus and PTH in dialysis patients.
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) today reported the receipt of Paragraph IV Certification Notice Letters related to certain drug manufacturers' Abbreviated New Drug Applications (ANDA) submitted to the U.S.
- A woman chauffeur.
- A woman who operates an automobile.